본문 바로가기 주메뉴 바로가기

제품소개

제품상세페이지

Others

[SEDIA] Sedia® HIV-1 Limiting Antigen (LAg)-Avidity EIA

Cat-No. 1002



SEDIA Biosciences Coporation은 감염병 진단과 공중보건 모니터링을 위한 신속 진단키트 및 샘플 수집 기술을 개발하는 미국 바이오 진단 기업입니다.





제품 설명


Sedia® HIV-1 Limiting Antigen (LAg)-Avidity EIA




제품 특징


An in vitro single well quantitative limiting antigen avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Intended for use with liquid serum or plasma specimens.

For Research Use Only: Not for use in diagnostic procedures.


Gold Standard for Incidence

Independent evaluation by CEPHIA showed lowest false recency rate of any HIV incidence assay evaluated.*

*Kassanjee R, Pilcher C, Keating S, et al. on behalf of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA), Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS 2014 Oct 23; 28(16) 2439-2449. Read Assessment


Designed for Surveillance

Can be used to estimate HIV-1 incidence in a population, monitor and evaluate HIV intervention programs, and recognize those high-incidence populations. Ensures prevention research, vaccine trials, and resources are most appropriately utilized.

Catalog NumberDescription
1002Sedia® HIV-1 LAg-Avidity EIA, For Research Use Only


PRODUCT SPECIFICATIONS

Summary of Specifications
Assay Time2-4 Hours
Processing Temperature15° to 37°C (59° to 98.6°F)
Storage TemperatureRefrigerator Pack: +2° to 8°C (35.6° to 46.4°F); Freezer Pack: -25° to -10°C (-13° to +14°F)
Specimen TypeHuman serum or plasma
Specimen Volume5 µL
Custom AntigenCustom, multi-clade CDC “rIDR-M” HIV-1 gp41 antigen that provides for reduced HIV-1 subtype bias
Mean Duration of Recent InfectionApproximately 130 days*
False Recency RateLess than 1%**
U.S. CDC QualifiedEach lot is performance tested by the U.S. Centers for Disease Control prior to market release
For Research Use OnlyNot for use in diagnostic procedures, RUO products are not to be used for diagnostic purposes, patient management, clinical purposes, or for investigational use within the U.S.
HIV Status RequirementIntended for use only with specimens previously diagnosed as HIV-1 positive




SEDIA Biosciences Coporation의 모든 제품을 만나 보세요!


Asanté® Rapid Point-of-Care Assays

Asanté® HIV-1 Rapid Recency®

Asanté® HIV-1/2 Oral Fluid Test


Sedia® HIV Lab Based Products

SEDIA® HIV-1 Lag-Avidity EIA




SEDIA Biosciences Corpoartion - Exclusive Distributor in South Korea "Morebio" 한국 독점 대리점 "모아바이오"